AIP Convertible Private Debt Fund LP, a 10% Holder, acquired 643,518 Common Shares on a direct ownership basis at a price of $1.080 through a prospectus or prospectus exempt offering on May 20th, 2022. This represents a $694,999 investment into the company's shares and an account share holdings change of 21.5%.
Elixxer is in the Investment Management & Fund Operators Sub Industry Group under the Financials Sector.
Elixxer Ltd. is a Canada-based cannabis investment company. The Company invests in cannabis related businesses, which are licensed for cultivation, production and/or sale of cannabis and cannabis derived products. It invests in cannabis industries, including nutraceutical, cosmetics, pharmaceutical, cultivation and extraction. It is primarily focused on medical cannabis and specialty cannabis derived products in the pharmaceutical sector. It grows and produces medical grade cannabis for global markets. It produces and develops a range of Cannabidiol (CBD) cosmetics and natural wellness CBD products. It also invests in facilities that allows cultivation, extraction and production of legal products. Its brands include Viridi, Easyjoint, Freia, Little Green Pharma (LGP) and One Premium Cannabis. The Company has investments in cannabis companies in Australia, Canada, Switzerland, Italy and Jamaica. Its subsidiaries include LGC Finance Limited, LGC Capital EU OU and LGC Capital Spain S.L.
No Comments